New-Onset Diabetes After Androgen-Deprivation Therapy For Prostate Cancer: A Nationwide Propensity Score-Matched Four-Year Longitudinal Cohort Study

Androgen-deprivation therapy (ADT) is important in the treatment of prostate cancer. However, the relationship between ADT and the risk of diabetes remains unclear, and the association between duration and types of ADT has not been fully investigated.AimTo examine the risk of developing type 2 diabetes mellitus (T2DM) in men who underwent ADT for prostate cancer.

Source: Journal of Diabetes and Its Complications - March 22, 2018 Category: Endocrinology Authors: Jhen-Hao Jhan, Hsin-Chih Yeh, Yu-Han Chang, Shiao-Jin Guu, Wen-Jeng Wu, Yii-Her Chou, Ching-Chia Li Source Type: research